IRIS Accounts Production v25.1.4.42 10003923 Board of Directors Board of Directors 1.3.24 28.2.25 28.2.25 horse trading. 0 0 false true false false true false 0 0 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh100039232024-02-29100039232025-02-28100039232024-03-012025-02-28100039232023-02-28100039232023-03-012024-02-29100039232024-02-2910003923ns15:EnglandWales2024-03-012025-02-2810003923ns14:PoundSterling2024-03-012025-02-2810003923ns10:Director12024-03-012025-02-2810003923ns10:Director22024-03-012025-02-2810003923ns10:PrivateLimitedCompanyLtd2024-03-012025-02-2810003923ns10:SmallEntities2024-03-012025-02-2810003923ns10:AuditExemptWithAccountantsReport2024-03-012025-02-2810003923ns10:SmallCompaniesRegimeForDirectorsReport2024-03-012025-02-2810003923ns10:SmallCompaniesRegimeForAccounts2024-03-012025-02-2810003923ns10:FullAccounts2024-03-012025-02-2810003923ns10:RegisteredOffice2024-03-012025-02-2810003923ns5:RetainedEarningsAccumulatedLosses2024-02-2910003923ns5:RetainedEarningsAccumulatedLosses2023-02-2810003923ns5:RetainedEarningsAccumulatedLosses2025-02-2810003923ns5:RetainedEarningsAccumulatedLosses2024-02-2910003923ns5:CurrentFinancialInstruments2025-02-2810003923ns5:CurrentFinancialInstruments2024-02-2910003923ns5:ShareCapital2025-02-2810003923ns5:ShareCapital2024-02-2910003923ns5:PlantMachinery2024-03-012025-02-2810003923ns5:OwnedAssets2024-03-012025-02-2810003923ns5:OwnedAssets2023-03-012024-02-2910003923ns5:PlantMachinery2024-02-2910003923ns5:PlantMachinery2025-02-2810003923ns5:PlantMachinery2024-02-2910003923ns5:WithinOneYearns5:CurrentFinancialInstruments2025-02-2810003923ns5:WithinOneYearns5:CurrentFinancialInstruments2024-02-29










REPORT OF THE DIRECTORS AND

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 28TH FEBRUARY 2025

FOR

KINGS BLOODSTOCK (SUSSEX) LIMITED

KINGS BLOODSTOCK (SUSSEX) LIMITED (REGISTERED NUMBER: 10003923)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28TH FEBRUARY 2025




Page

Company Information 1

Report of the Directors 2

Statement of Income and Retained Earnings 3

Balance Sheet 4

Notes to the Financial Statements 5


KINGS BLOODSTOCK (SUSSEX) LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 28TH FEBRUARY 2025







DIRECTORS: E Eismark
A Carr





REGISTERED OFFICE: C/o Evans Weir
The Victoria
25 St Pancras
Chichester
West Sussex
PO19 7LT





REGISTERED NUMBER: 10003923 (England and Wales)





ACCOUNTANTS: Evans Weir
The Victoria
25 St Pancras
Chichester
West Sussex
PO19 7LT

KINGS BLOODSTOCK (SUSSEX) LIMITED (REGISTERED NUMBER: 10003923)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 28TH FEBRUARY 2025

The directors present their report with the financial statements of the company for the year ended 28th February 2025.

DIRECTORS
The directors shown below have held office during the whole of the period from 1st March 2024 to the date of this report.

E Eismark
A Carr

This report has been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

ON BEHALF OF THE BOARD:





E Eismark - Director


4th August 2025

KINGS BLOODSTOCK (SUSSEX) LIMITED (REGISTERED NUMBER: 10003923)

STATEMENT OF INCOME AND
RETAINED EARNINGS
FOR THE YEAR ENDED 28TH FEBRUARY 2025

2025 2024
Notes £    £   

TURNOVER 282,139 45,734

Cost of sales 226,352 37,162
GROSS PROFIT 55,787 8,572

Administrative expenses 17,724 9,131
OPERATING PROFIT/(LOSS) 4 38,063 (559 )

Interest receivable and similar income - 3
38,063 (556 )

Interest payable and similar expenses - 20
PROFIT/(LOSS) BEFORE TAXATION 38,063 (576 )

Tax on profit/(loss) - 2
PROFIT/(LOSS) FOR THE FINANCIAL
YEAR

38,063

(578

)

Retained earnings at beginning of year (64,926 ) (64,348 )

RETAINED EARNINGS AT END OF
YEAR

(26,863

)

(64,926

)

KINGS BLOODSTOCK (SUSSEX) LIMITED (REGISTERED NUMBER: 10003923)

BALANCE SHEET
28TH FEBRUARY 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 5 453 690

CURRENT ASSETS
Stocks 32,147 77,994
Debtors 6 - 5,640
Cash at bank 35,672 8,495
67,819 92,129
CREDITORS
Amounts falling due within one year 7 95,035 157,645
NET CURRENT LIABILITIES (27,216 ) (65,516 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(26,763

)

(64,826

)

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings (26,863 ) (64,926 )
SHAREHOLDERS' FUNDS (26,763 ) (64,826 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 28th February 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 28th February 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 4th August 2025 and were signed on its behalf by:




E Eismark - Director



A Carr - Director


KINGS BLOODSTOCK (SUSSEX) LIMITED (REGISTERED NUMBER: 10003923)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28TH FEBRUARY 2025

1. STATUTORY INFORMATION

Kings Bloodstock (Sussex) Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

There was a next deficiency of assets of £64,925 at the balance sheet date, however the directors have confirmed continued support and consider that the company retains sufficient working capital to continue trading for the foreseeable future.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - Straight line over 3 years

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2024 - NIL).

KINGS BLOODSTOCK (SUSSEX) LIMITED (REGISTERED NUMBER: 10003923)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 28TH FEBRUARY 2025

4. OPERATING PROFIT/(LOSS)

The operating profit (2024 - operating loss) is stated after charging:

2025 2024
£    £   
Depreciation - owned assets 237 20

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1st March 2024
and 28th February 2025 710
DEPRECIATION
At 1st March 2024 20
Charge for year 237
At 28th February 2025 257
NET BOOK VALUE
At 28th February 2025 453
At 29th February 2024 690

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors - 5,640

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade creditors 41,185 -
Taxation and social security 7,326 1,053
Other creditors 46,524 156,592
95,035 157,645

8. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The directors have made loans to the company of £44,524.